Similar sensitivity of regulatory T cells towards CD95L-mediated apoptosis in patients with multiple sclerosis and healthy individuals

Journal of the Neurological Sciences

Volumn 251, Issue 1-2, 2006, Pages 91-97

  Fritzsching, Benedikt ^a,b   Korporal, Mirjam ^b   Haas, Jürgen ^b   Krammer, Peter H ^a   Suri Payer, Elisabeth ^a   Wildemann, Brigitte ^b  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Apoptosis; Autoimmunity; CD95; Multiple sclerosis; Regulatory T cells

Indexed keywords

FAS LIGAND; INTERLEUKIN 2; T LYMPHOCYTE RECEPTOR;

ADULT; APOPTOSIS; ARTICLE; AUTOIMMUNITY; CONTROLLED STUDY; HUMAN; HUMAN CELL; MULTIPLE SCLEROSIS; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; SENSITIVITY ANALYSIS; SIGNAL TRANSDUCTION;

ADULT; ANTIGENS, CD95; APOPTOSIS; CASE-CONTROL STUDIES; CELL COUNT; CELL PROLIFERATION; CELLS, CULTURED; FAS LIGAND PROTEIN; FEMALE; FLOW CYTOMETRY; HUMANS; INTERLEUKIN-2; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA; T-LYMPHOCYTES; T-LYMPHOCYTES, REGULATORY;

EID: 33751227462     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jns.2006.09.006     Document Type: Article

References (45)

1. Martin R., and McFarland H.F. Immunological aspects of experimental allergic encephalomyelitis and multiple sclerosis. Crit Rev Clin Lab Sci 32 (1995) 121-182
2. Steinman L. Myelin-specific CD8 T cells in the pathogenesis of experimental allergic encephalitis and multiple sclerosis. J Exp Med 194 (2001) F27-F30
3. Hafler D.A., Slavik J.M., Anderson D.E., O'Connor K.C., De Jager P., and Baecher-Allan C. Multiple sclerosis. Immunol Rev 204 (2005) 208-231
4. Ota K., Matsui M., Milford E.L., Mackin G.A., Weiner H.L., and Hafler D.A. T-cell recognition of an immunodominant myelin basic protein epitope in multiple sclerosis. Nature 346 (1990) 183-187
5. Pullen A.M., Marrack P., and Kappler J.W. Evidence that Mls-2 antigens which delete V beta 3+ T cells are controlled by multiple genes. J Immunol 142 (1989) 3033-3037
6. Lovett-Racke A.E., Trotter J.L., Lauber J., Perrin P.J., June C.H., and Racke M.K. Decreased dependence of myelin basic protein-reactive T cells on CD28-mediated costimulation in multiple sclerosis patients. A marker of activated/memory T cells. J Clin Invest 101 (1998) 725-730
7. Reijonen H., Novak E.J., Kochik S., Heninger A., Liu A.W., Kwok W.W., and Nepom G.T. Detection of GAD65-specific T-cells by major histocompatibility complex class II tetramers in type 1 diabetic patients and at-risk subjects. Diabetes 51 (2002) 1375-1382
8. Scholz C., Patton K.T., Anderson D.E., Freeman G.J., and Hafler D.A. Expansion of autoreactive T cells in multiple sclerosis is independent of exogenous B7 costimulation. J Immunol 160 (1998) 1532-1538
9. Viglietta V., Kent S.C., Orban T., and Hafler D.A. GAD65-reactive T cells are activated in patients with autoimmune type 1a diabetes. J Clin Invest 109 (2002) 895-903
10. Sakaguchi S. Naturally arising CD4+ regulatory t cells for immunologic self-tolerance and negative control of immune responses. Annu Rev Immunol 22 (2004) 531-562
11. Putnam A.L., Vendrame F., Dotta F., and Gottlieb P.A. CD4+CD25high regulatory T cells in human autoimmune diabetes. J Autoimmun 24 (2005) 55-62
12. Kukreja A., Cost G., Marker J., Zhang C., Sun Z., Lin-Su K., et al. Multiple immuno-regulatory defects in type-1 diabetes. J Clin Invest 109 (2002) 131-140
13. de Kleer I.M., Wedderburn L.R., Taams L.S., Patel A., Varsani H., Klein M., et al. CD4+CD25bright regulatory T cells actively regulate inflammation in the joints of patients with the remitting form of juvenile idiopathic arthritis. J Immunol 172 (2004) 6435-6443
14. Crispin J.C., Martinez A., and Alcocer-Varela J. Quantification of regulatory T cells in patients with systemic lupus erythematosus. J Autoimmun 21 (2003) 273-276
15. Boyer O., Saadoun D., Abriol J., Dodille M., Piette J.C., Cacoub P., et al. CD4+CD25+ regulatory T-cell deficiency in patients with hepatitis C-mixed cryoglobulinemia vasculitis. Blood 103 (2004) 3428-3430
16. Kriegel M.A., Lohmann T., Gabler C., Blank N., Kalden J.R., and Lorenz H.M. Defective suppressor function of human CD4+ CD25+ regulatory T cells in autoimmune polyglandular syndrome type II. J Exp Med 199 (2004) 1285-1291
17. Sugiyama H., Gyulai R., Toichi E., Garaczi E., Shimada S., Stevens S.R., et al. Dysfunctional blood and target tissue CD4+CD25high regulatory T cells in psoriasis: mechanism underlying unrestrained pathogenic effector T cell proliferation. J Immunol 174 (2005) 164-173
18. Luther C., Poeschel S., Varga M., Melms A., and Tolosa E. Decreased frequency of intrathymic regulatory T cells in patients with myasthenia-associated thymoma. J Neuroimmunol 164 (2005) 124-128
19. Viglietta V., Baecher-Allan C., Weiner H.L., and Hafler D.A. Loss of functional suppression by CD4+CD25+ regulatory T cells in patients with multiple sclerosis. J Exp Med 199 (2004) 971-979
20. Haas J., Hug A., Viehover A., Fritzsching B., Falk C.S., Filser A., et al. Reduced suppressive effect of (CD4+)CD25high regulatory T cells on the T cell immune response against myelin oligodendrocyte glycoprotein in patients with multiple sclerosis. Eur J Immunol 35 (2005) 3343-3352
21. Fritzsching B., Oberle N., Eberhardt N., Quick S., Haas J., Wildemann B., et al. In contrast to effector T cells, CD4+CD25+FoxP3+ regulatory T cells are highly susceptible to CD95 ligand- but not to TCR-mediated cell death. J Immunol 175 (2005) 32-36
22. Schmitz I., Weyd H., Krueger A., Baumann S., Fas S.C., Krammer P.H., et al. Resistance of short term activated T cells to CD95-mediated apoptosis correlates with de novo protein synthesis of c-FLIPshort. J Immunol 172 (2004) 2194-2200
23. Krammer P.H. CD95's deadly mission in the immune system. Nature 407 (2000) 789-795
24. Pender M.P. Genetically determined failure of activation-induced apoptosis of autoreactive T cells as a cause of multiple sclerosis. Lancet 351 (1998) 978-981
25. Comi C., Leone M., Bonissoni S., DeFranco S., Bottarel F., Mezzatesta C., et al. Defective T cell fas function in patients with multiple sclerosis. Neurology 55 (2000) 921-927
26. Macchi B., Matteucci C., Nocentini U., Caltagirone C., and Mastino A. Impaired apoptosis in mitogen-stimulated lymphocytes of patients with multiple sclerosis. Neuroreport 10 (1999) 399-402
27. Sharief M.K. Impaired fas-independent apoptosis of T lymphocytes in patients with multiple sclerosis. J Neuroimmunol 109 (2000) 236-243
28. Zipp F., Faber E., Sommer N., Muller C., Dichgans J., Krammer P.H., et al. CD95 expression and CD95-mediated apoptosis of T cells in multiple sclerosis. No differences from normal individuals and no relation to HLA-DR2. J Neuroimmunol 81 (1998) 168-172
29. Pelfrey C.M., Tranquill L.R., Boehme S.A., McFarland H.F., and Lenardo M.J. Two mechanisms of antigen-specific apoptosis of myelin basic protein (MBP)-specific T lymphocytes derived from multiple sclerosis patients and normal individuals. J Immunol 154 (1995) 6191-6202
30. Poser C.M., Paty D.W., Scheinberg L., McDonald W.I., Davis F.A., Ebers G.C., et al. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 13 (1983) 227-231
31. Igney F.H., Behrens C.K., and Krammer P.H. The influence of CD95L expression on tumor rejection in mice. Eur J Immunol 33 (2003) 2811-2821
32. Taams L.S., Smith J., Rustin M.H., Salmon M., Poulter L.W., and Akbar A.N. Human anergic/suppressive CD4(+)CD25(+) T cells: a highly differentiated and apoptosis-prone population. Eur J Immunol 31 (2001) 1122-1131
33. McGeachy M.J., Stephens L.A., and Anderton S.M. Natural recovery and protection from autoimmune encephalomyelitis: contribution of CD4+CD25+ regulatory cells within the central nervous system. J Immunol 175 (2005) 3025-3032
34. Beyersdorf N., Gaupp S., Balbach K., Schmidt J., Toyka K.V., Lin C.H., et al. Selective targeting of regulatory T cells with CD28 superagonists allows effective therapy of experimental autoimmune encephalomyelitis. J Exp Med 202 (2005) 445-455
35. Hoffmann P., Eder R., Kunz-Schughart L.A., Andreesen R., and Edinger M. Large-scale in vitro expansion of polyclonal human CD4(+)CD25high regulatory T cells. Blood 104 (2004) 895-903
36. Earle K.E., Tang Q., Zhou X., Liu W., Zhu S., Bonyhadi M.L., et al. In vitro expanded human CD4+CD25+ regulatory T cells suppress effector T cell proliferation. Clin Immunol 115 (2005) 3-9
37. Rathmell J.C., and Thompson C.B. Pathways of apoptosis in lymphocyte development, homeostasis, and disease. Cell 109 (2002) S97-S107 [Suppl]
38. Aktas O., Ari N., Rieks M., Hoffmann V., Schimrigk S., Przuntek H., et al. Multiple sclerosis: modulation of apoptosis susceptibility by glatiramer acetate. Acta Neurol Scand 104 (2001) 266-270
39. Zipp F., Martin R., Lichtenfels R., Roth W., Dichgans J., Krammer P.H., et al. Human autoreactive and foreign antigen-specific T cells resist apoptosis induced by soluble recombinant CD95 ligand. J Immunol 159 (1997) 2108-2115
40. Zang Y.C., Kozovska M.M., Hong J., Li S., Mann S., Killian J.M., et al. Impaired apoptotic deletion of myelin basic protein-reactive T cells in patients with multiple sclerosis. Eur J Immunol 29 (1999) 1692-1700
41. Saresella M. Programmed cell death of myelin basic protein-specific T lymphocytes is reduced in patients with acute multiple sclerosis. J Neuroimmunol 166 (2005) 173-179
42. Gomes A.C., Morris M., Stawiarz L., Jonsson G., Putheti P., Bronge L., et al. Decreased levels of CD95 and caspase-8 mRNA in multiple sclerosis patients with gadolinium-enhancing lesions on MRI. Neurosci Lett 352 (2003) 101-104
43. Macchi B., Matteucci C., Nocentini U., Tacconi S., Pagnini V., Mastino A., et al. Defective fas ligand production in lymphocytes from MS patients. Neuroreport 12 (2001) 4113-4116
44. Ichikawa H., Ota K., and Iwata M. Increased fas antigen on T cells in multiple sclerosis. J Neuroimmunol 71 (1996) 125-129
45. McDonald W.I., Compston A., Edan G., Goodkin D., Hartung P., Lublin F.D., et al. Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann Neurol 50 (2001) 121-127